BRIEF-GSK says seeking U.S. approval for expanded indication for influenza vaccine
February 02, 2016 at 09:05 AM EST
* Announces U.S. regulatory submission seeking expanded indication for flulaval quadrivalent (influenza vaccine) for infants 6 mos+